人参

Search documents
近四百企业组团推介辽宁“好贺”
Liao Ning Ri Bao· 2025-07-13 00:59
开在家门口的粮交会,为我省粮油企业搭建了交流、合作、商贸的平台。作为稻米生产、加工的优 势地区,营口大石桥市水稻年产量6.6亿斤,年加工能力100万吨以上,并催生了35家龙头企业,此次组 团30余家粮食企业、农副产品企业、工业企业参会,是以往赴外省参加粮交会企业数量的15倍。 7月12日,第七届中国粮食交易大会在沈阳开幕。辽宁与陕西、安徽、山西、浙江等13个省区达成 战略合作,大会开幕式签约项目10个。在辽宁展区同期活动中,我省粮油企业与省内外客商签约项目24 个,达成交易金额40亿元。辽宁"好贺"获得广泛青睐和市场认可。 开幕式当天,粮交会还举行了粮食政策和市场形势分析会,邀请专家学者围绕全国粮食市场供需形 势、推动期货现货结合业务提升粮食统一大市场竞争力、数字营销助力粮食流通提质增效等进行解读。 这是辽宁首次承办粮交会。本届粮交会采用沈阳1个主会场加盘锦、朝阳2个分会场模式,展会面积 超10万平方米,其中沈阳主会场展览面积8.3万平方米。共有4000多家企业、2万余名行业人员参展参 会。本届粮交会办会规模、参展企业数量、嘉宾规模均创新高。其中,辽宁展区共有399家企业参展, 参展面积7400平方米。 "我 ...
让知识产权更好赋能东北振兴
Jing Ji Ri Bao· 2025-07-11 22:15
Group 1 - The effective invention patents in Northeast China reached 195,000 by the end of April this year, representing a year-on-year growth of 10.2% [1] - The effective registered trademarks in the region totaled 2.161 million, with a year-on-year increase of 7.7% [1] - The total number of geographical indication products recognized reached 273, with 556 registrations approved for collective and certification trademarks, accounting for nearly one-tenth of the national total [1] Group 2 - Intellectual property (IP) is becoming a crucial mechanism for driving technological innovation and enhancing industrial competitiveness in Northeast China [1][2] - The region is leveraging its manufacturing base and technical talent to address issues such as technological obsolescence and low added value in traditional industries through IP [2] - Knowledge property operation centers have been established in traditional industries like dairy and grass, promoting the transformation and application of patent achievements in green manufacturing and ecological agriculture [2] Group 3 - The Northeast region has natural advantages for developing strategic emerging industries, such as artificial intelligence and big data, due to its climate and resource conditions [3] - Eight national-level IP protection and rapid response centers have been established in Northeast China, focusing on key areas like high-end equipment manufacturing and biomedicine [3] - By the end of 2024, the effective invention patents in strategic emerging industries in the region are expected to reach 46,000, showing significant growth compared to the previous year [3] Group 4 - In the process of rural revitalization, IP is providing core added value for agricultural products to enter high-end markets [4] - The region is implementing a brand protection strategy, with notable brands like Wuchang rice and Changbai Mountain ginseng gaining national recognition [4] - Thirteen national-level geographical indication protection demonstration zones have been established, promoting the transformation of geographical indications from "regional labels" to "industrial clusters" [4]
图们:筑牢市场监管防线绘就旅游市场新篇
Sou Hu Cai Jing· 2025-07-10 04:11
为规范旅游市场秩序,切实维护消费者合法权益,图们市市场监督管理局开展旅游市场专项整治行动,立足市场监管职能,聚焦关键重点领域,着力提升旅 游市场服务质量。 锚定价格稳定线,擦亮诚信新底色。持续推进明码标价制度,重点对辖区内人参等土特产商品销售区域开展专项整治,要求商户按品级分类摆放商品,统一 规范价格标签,杜绝以次充好、虚假宣传等行为,做到"去伪存真",已为10家人参土特产商户发放人参定制价签500余张。同时,为维护公平竞争市场环 境,组织召开行业约谈会,督促企业落实主体责任,推动商户签订诚信经营承诺书。 疏堵结合促发展,绘就市场新图景。为整治违法占道经营,减少交通拥堵风险,消除食品安全隐患,维护城市整体形象,市市监局联合市城管大队、市文广 旅局等多部门开展联合执法行动,并同步推进旅游商业街区规范化建设,为24户流动商户颁发吉林省食品摊贩备案卡,引导其入驻正规经营场所。同时,定 期排查食品安全隐患,提供经营指导服务,保障民生就业需求,实现旅游市场环境提质升级。 来源:图们市委宣传部 织密食安防护网,筑牢民生健康墙。以"全覆盖、零死角"为目标,以"定期检查、专项检查、随机抽查"为抓手,围绕食品原料采购、储存、加 ...
探寻“北丝绸之路”的前世今生(边城见闻)
Ren Min Ri Bao· 2025-07-08 22:19
Group 1: Historical Significance - The "North Silk Road" serves as a trade route and cultural bridge, connecting ancient Chang'an to Northeast Asia, with its core segment located in today's Baishan City, Jilin Province [12][13] - Baishan City, known for its rich natural resources, has historically facilitated the exchange of goods like ginseng and pine nuts, contributing to cultural interactions with countries like Japan and Silla [12][15] Group 2: Ginseng Market Dynamics - The Wanliang Changbai Mountain Ginseng Market is recognized as the world's largest national-level ginseng trading market, with a trading volume of 59.5 million pounds of fresh ginseng and a revenue of 2.41 billion RMB in 2024 [16][17] - The market has transitioned from selling raw materials to high-value products, with companies like Daziran Bioengineering Co. focusing on deep processing, achieving prices of 35,000 RMB per kilogram for ginsenosides [17][18] Group 3: Cultural Exchange and Tourism - The region has become a global tourism destination, leveraging its natural attractions and cultural heritage, including the unique ginseng harvesting customs recognized as a national intangible cultural heritage [19][20] - Initiatives to enhance the international visitor experience include bilingual services and cultural activities, promoting the integration of ginseng culture with tourism [19][20]
中国香妆品牌发展大会上海召开 谷雨斩获“2025国货美白护肤第一”
Cai Fu Zai Xian· 2025-07-08 08:33
7月1日,由中国香料香精化妆品工业协会、上海市奉贤区人民政府联合主办,东方美谷企业集团股份有 限公司承办,新华网、FBeauty未来迹协办的"中国香妆品牌发展大会"在上海东方美谷盛大开幕。 本次大会以"创新驱动品牌腾飞"为主题,聚焦中国化妆品行业的高质量发展,并首次发布基于全渠道零 售规模与品牌综合实力的三大权威榜单——"2025化妆品企业50强""2025化妆品品牌50强"及"2025化妆 品品类冠军"。作为行业首创的全新坐标系,三大榜单的发布将在为品牌发展提供科学量化的评估基 准,助力中国化妆品产业在全球竞争中提升话语权。 在此次权威评选中,国货先锋品牌谷雨凭借突破性的科技创新能力、独特的品牌文化构建能力以及消费 市场出色的口碑及销售表现,成功登榜"2025化妆品企业50强"及"2025化妆品品牌50强",同时更揽 获"2025品类冠军·国货美白护肤第一品牌"市场地位的权威认证。 图:国货美白护肤第一品牌 谷雨 科研筑基 引领美白市场消费选择 作为国内首个主打"光甘草定"美白的护肤品牌,早在品牌成立前的2007 年便成立专研护肤实验室,这 使得品牌对光甘草定的研究长达18年之久并带来瞩目成果。 图:谷雨" ...
职工和药厂勾结、虚假开药 上海两家民营中医馆骗保1200余万元
Yang Shi Xin Wen Ke Hu Duan· 2025-07-04 06:36
Core Insights - The Shanghai police have dismantled a healthcare fraud ring involving a designated medical institution, which has committed over 50,000 fraudulent claims amounting to more than 120 million yuan in two years [1][13]. Group 1: Fraud Scheme Details - The fraud was orchestrated by the Yiyang Traditional Chinese Medicine Hospital, where internal staff colluded with external pharmaceutical companies to submit false claims [3][9]. - Investigations revealed that many insured individuals did not actually visit the hospital, yet their records showed multiple prescriptions and treatments [3][9]. - A specific employee, Zhao, was noted for bringing numerous neighbors to the hospital, resulting in over 300 visits in just six months [5]. Group 2: Investigation Findings - The police found that during visits, patients were not properly examined; instead, they were simply asked to sign and pay without any consultation [7]. - Data comparisons indicated that while only 2 to 3 patients were present, records showed over 10 visits, indicating a systematic fraud operation [9]. - Some staff members were involved in swapping expensive herbal medicines for cheaper alternatives, further complicating the fraud [11]. Group 3: Legal Actions and Outcomes - Following the identification of the fraud ring's structure, a major operation in October led to the arrest of 34 suspects, with additional arrests of 56 insured individuals in April [13]. - The fraud ring was led by a figure named Yan, who coordinated with stakeholders from the involved medical institutions to execute the fraudulent activities [13].
吉林通化人参产业前五月产值超156亿元
Zhong Guo Chan Ye Jing Ji Xin Xi Wang· 2025-07-04 00:52
人参产业是吉林省通化市的特色优势产业,数据显示,1-5月通化市人参产业综合产值达156.94亿元。 近年来,通化市以"四好""三良"全产业链协同发展为抓手,有效巩固一产基础,科学规划种植区域,推 广生态种植模式;大力提升二产能级,坚定发展精深加工,支持龙头企业做大做强,引进战略投资,重 点突破高科技产品研发和产业化;创新发展三产融合,深入挖掘人参文化内涵,大力发展文旅康养业 态,打造集人参种植、观光体验、休闲度假等于一体的特色旅游线路和研学基地,提升产业附加值和文 化软实力。 种植领域,通化市林下参种植面积32.09万亩,产量和产值分别占全省的85.40%、86.42%,园参留存面 积4.68万亩,产量和产值分别占全省的26.15%、26.12%;加工领域,全市现有人参加工企业450余户, 规上生产企业28户;销售领域,通化拥有清河澳洋野山参国际交易市场和通化快大人参交易市场两大人 参市场,2024年交易总额165亿元,其中澳洋市场的野山参交易量占全国总量的80%以上;科研领域, 通化拥有张伯礼院士工作站、吉林人参研究院等7家科研机构和1个国家技术标准创新基地,取得省级以 上科研成果40项,制定人参种植、加工 ...
“朋克养生”年轻人,喝出100亿大买卖
3 6 Ke· 2025-07-01 23:28
"熬着最晚的夜,吃着最多的养生品",年轻人一边"作死"一边自救的"朋克养生法",让养生经济的发展势如破竹。 从八段锦到泡脚包,从健康轻食到中药奶茶,但凡跟养生沾上边的东西总能火一把。而如今,饮品商家也看到了这一巨大的市场,开始了中式养生水的开 发之路,无论是主打祛湿的红豆薏米水、清热解毒的绿豆水,还是提气补血的人参水,都深受广大年轻"养生爱好者"的青睐。 在可漾成为第一个吃螃蟹的人后,2023年初,元气森林的加入让这个市场燃起了更大的活力,"元气自在水"系列也成为了元气森林自气泡水和电解质水之 后的第三个"十亿销量"单品。 从传统饮品到新锐玩家,各大品牌纷纷入局,在如此火热的浪潮中,谁能在养生水赛道大赚特赚呢? 各路玩家纷纷入局养生水 露露告诉Tech星球,她第一次尝试养生水是在去年夏天,看到身边同事在喝成瓶的绿豆汤,询问后才知道是元气森林的新品。 "我喝完之后,就立刻下单囤了三箱,虽然不能确定具体的养生效果,但它的健康概念确实给了我一种心理上的慰藉。虽然价格比普通饮料贵一些,但是 因为有心理满足感,总会忍不住买来代替水喝。" 一位养生水代理商告诉Tech星球,中式养生水的目标客户人群,基本是20到35岁的年 ...
药食同源产业已成为大健康领域的核心风口
Zhong Guo Shi Pin Wang· 2025-07-01 09:38
Core Insights - The Chinese medicinal food market is projected to reach 265 billion yuan in 2024, with an 18% year-on-year growth, and is expected to exceed 370 billion yuan by 2025, with the entire industry chain valued at over 2 trillion yuan [1] Policy Benefits - Continuous expansion of the catalog: The National Health Commission is accelerating updates to the "Medicinal Food Catalog," adding four new substances in 2024, bringing the total to 106 by June 2025, providing greater space for product development [1] - Regulatory standardization: A "full-chain traceability" system for food safety will be launched in 2024, requiring companies to upload complete process data; the "negative list management" proposed during the Two Sessions will strengthen raw material safety and efficacy claims, raising industry entry barriers [1] Consumer Demand - Young demographics as the main force: 90% of post-90s individuals have health preservation awareness, with over half taking action; new concepts like "health coffee" and "water substitutes" are gaining popularity, with products like ginseng coffee and yellow essence latte appealing to younger consumers [2] - Diversification of consumption scenarios: The market is shifting from health supplements to daily consumption, exemplified by Hema's upgraded "Traditional Health Water" and ready-to-eat medicinal dishes like Rehmannia chicken soup and yam pork rib soup [2] Industry Innovation and Technology - Product form innovation: Food products now account for 60% of the market, with trends towards instant and snackable formats; for instance, "Yuzhu Lily Drink" retains over 90% of polysaccharides through low-temperature extraction, balancing efficacy and taste [3] - Technology empowering the supply chain: Leading companies are using AI climate models for cultivation, increasing ginsenoside content by 20%; yeast synthesis of ganoderic acid has reduced costs by 40% [3] - Accelerated cross-industry integration: Traditional brands like Tongrentang and Li Liangji are collaborating with Hema to launch health afternoon teas; coffee brands are incorporating ginseng and ganoderma to enhance functionality [3] Social Value and Industry Linkage - Supporting rural revitalization: The cultivation of medicinal food raw materials is driving large-scale development in various regions, such as Guizhou Yuankun Pharmaceutical establishing GAP bases for local medicinal materials, creating a "planting-processing-branding" industry chain [4] - Practicing the "big food concept": The expansion of the catalog promotes the foodification of medicinal materials, broadening food sources and enhancing added value [4]
非经营性资金占用且信披违法 维康药业与6名高管被罚1600万元
Zhong Guo Jing Ying Bao· 2025-06-30 13:04
Core Viewpoint - The company Weikang Pharmaceutical (300878.SZ) has been penalized 16 million yuan due to non-operational fund occupation by its actual controller and violations in information disclosure [2][3][6]. Group 1: Regulatory Actions and Penalties - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Weikang Pharmaceutical and its actual controller Liu Zhongliang for suspected violations of information disclosure [3]. - The CSRC found that from 2020 to 2023, Liu Zhongliang organized and directed the company to transfer funds under the guise of paying for engineering equipment, which were ultimately transferred to his personal accounts, constituting non-operational fund occupation [3][5]. - The total penalties include 5 million yuan for Weikang Pharmaceutical, 7 million yuan for Liu Zhongliang, and 4 million yuan for five other executives, totaling 16 million yuan [6]. Group 2: Financial Performance and Issues - Weikang Pharmaceutical has experienced a decline in performance since its listing in August 2020, with consecutive losses in 2023 and 2024 [4][10]. - The net profits from 2021 to 2023 were 97 million yuan, 49 million yuan, and a loss of 9 million yuan, respectively [9]. - In 2024, the company reported a loss of 147 million yuan, with a particularly poor performance in the fourth quarter, where revenue was negative 20 million yuan [10][11]. Group 3: Operational Challenges - The company attributes its declining performance to several factors, including reduced demand for prescription drugs due to changes in medical insurance policies and market conditions, increased competition leading to lower gross margins, and a shift in product promotion strategies [10]. - In 2024, Weikang Pharmaceutical's sales expenses were 201 million yuan, accounting for 57.26% of its revenue, while R&D expenses were only 14 million yuan, representing 4% of revenue, a decrease of 66.85% year-on-year [10]. Group 4: Corporate Governance Changes - Due to the fund occupation issues, two executives left their positions, with Liu Zhongliang resigning as chairman and director in May 2024 [7].